FDA Approves Genentech's Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
FDA Approves Genentech's Tecentriq Plus Lurbinectedin as Fi…
7 months ago
finanznachrichten.de
Cancer starts when normal biological signals in the body go haywire, also known as dysregulation. In breast cancer, one of the most common signals that can go haywire is called PI3K, which controls how cells grow and stay healthy. Learn more from our Lead Medical Director, Jennifer Schutzman who uses everyday objects to explain this critical pathway in breast cancer and efforts to target it more precisely than ever before. Learn more and watch the full video series: https://www.gene.com/stories/
2:06
Cancer starts when normal biological signals in the body go h…
187 viewsNov 12, 2024
FacebookGenentech
Multiple sclerosis affects everyone differently, but one thing is consistent - progression can start early and be unpredictable. Learn how to work with a healthcare provider to better understand and track this progression. | Genentech
0:22
Multiple sclerosis affects everyone differently, but one thing is consis…
148.6K views11 months ago
FacebookGenentech
Ocrelizumab | Genentech Prescribing & Product Information
3:18
Ocrelizumab | Genentech Prescribing & Product Information
10 months ago
genentech-medinfo.com
Today, the FDA granted accelerated approval for a new targeted medicine that treats the most aggressive form of #lymphoma. Watch our video to learn more about diffuse large B-cell lymphoma (DLBCL): http://bit.ly/2I5sd5L | Genentech
0:31
Today, the FDA granted accelerated approval for a new targeted medic…
63.7K viewsJun 10, 2019
FacebookGenentech
Many personalized cancer treatments aim to block out-of-control signals that fuel tumor growth. Targeting the PI3K pathway, which drives the growth of many cancers including #breastcancer, has been a challenging goal for researchers. Anwesha Dey, Senior Director & Scientist in Discovery Oncology at Genentech, uses everyday objects to explain how discoveries are enabling a new scientific advancement which not only blocks mutated signals, but also destroys the mutated proteins. | Genentech
1:31
Many personalized cancer treatments aim to block out-of-con…
274.9K viewsNov 14, 2024
FacebookGenentech
Do you know what questions to ask if you or a loved one is diagnosed with breast cancer? Learn more about the different types of the disease and questions to ask your doctor. | Genentech
0:16
Do you know what questions to ask if you or a loved one is diagnosed …
72.8K viewsNov 28, 2019
FacebookGenentech
0:50
Lori was diagnosed with ALK lung cancer despite being a non-smoke…
60.4K viewsNov 9, 2018
FacebookGenentech
Single cell & label free binding affinity: applications with Genentech
Apr 27, 2021
labroots.com
PD-L1/PD-1 Pathway: A Security Checkpoint‬
May 12, 2015
gene.com
Genentech Advances Prasinezumab To Phase III Trials In Early Parkins…
10 months ago
finanznachrichten.de
6:12
Molecular Testing Report: IHC for PD-L1 and NGS of RNA - Lung Ca…
4 views2 weeks ago
YouTubeGlobal Resource for Advancing Cancer Education
13:27
Genetec Overview
1.4K viewsAug 14, 2019
YouTubeMichael OConnor
2:05
Apoptotic Pathways
409.3K viewsNov 13, 2012
YouTubeGenentech
1:40
Angiogenic Signaling
92.2K viewsNov 13, 2012
YouTubeGenentech
1:50
The PI3K Signaling Pathway
153.3K viewsNov 13, 2012
YouTubeGenentech
1:54
The MAPK Signaling Pathway
215.5K viewsNov 13, 2012
YouTubeGenentech
1:07
How Does Anti-PD-1 Therapy Help Fight Cancer?
9.5K viewsMay 24, 2017
YouTubeJohns Hopkins Medicine
1:39
B-cell Surface Proteins
39K viewsNov 13, 2012
YouTubeGenentech
1:41
The HER Signaling Pathway
57.9K viewsNov 13, 2012
YouTubeGenentech
4:33
The HER Pathway and Cancer
93.9K viewsJun 11, 2012
YouTubeGenentech
3:41
A Place for New Perspectives
84.7K viewsFeb 26, 2013
YouTubeGenentech
3:19
A Turning Point for Cancer Vaccines
76.8K viewsSep 16, 2016
YouTubeGenentech
5:09
MHC-I Processing | Antigen Processing and Presentation
113.7K viewsJul 15, 2019
YouTubeHussain Biology
3:24
G-protein coupled receptors (GPCRs)
151.3K viewsJun 18, 2018
YouTubeRandom42 Scientific Communication
8:09
Antigen Processing and Presentation (PART I): MHC I Anti…
369.5K viewsNov 14, 2017
YouTubeFrank Lectures
1:16
Explaining Immunotherapy, PD-L1 and PD-1
40.2K viewsSep 14, 2020
YouTubeAmerican Lung Association
4:00
Cancer Immunotherapy - PD-1 and PD-L1
274.9K viewsAug 5, 2014
YouTubeImmunoOncology
5:12
Antigen Processing and Presentation (PART II): MHC II Anti…
219.5K viewsMay 1, 2017
YouTubeFrank Lectures
6:56
All you need to know about PD-L1 by Immunohistochemistry
3.7K viewsFeb 11, 2021
YouTubeMetropolis Lab
See more videos
Static thumbnail place holder